rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MTNB
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Matinas BioPharma announces one-for-fifteen reverse stock split approval
      Sep 17Investing.comMTNB
      Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

      BEDMINSTER, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on August 31, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.

      Sep 4Yahoo FinanceMTNB

      This is the newest page. Registered accounts read further back.